CV Sciences (CVSI) Capital Expenditures (QoQ) (2013 - 2026)
CV Sciences (CVSI) Capital Expenditures (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.67% |
| Dec 31, 2025 | -18.18% |
| Sep 30, 2025 | -77.55% |
| Jun 30, 2025 | 22.50% |
| Mar 31, 2025 | 122.22% |
| Mar 31, 2021 | 115.63% |
| Dec 31, 2020 | 16.10% |
| Sep 30, 2020 | -1,126.92% |
| Jun 30, 2020 | -94.58% |
| Mar 31, 2020 | 159.11% |
| Dec 31, 2019 | -304.53% |
| Sep 30, 2019 | -21.23% |
| Dec 31, 2018 | -334.75% |
| Sep 30, 2018 | 171.15% |
| Jun 30, 2018 | -62.32% |
| Mar 31, 2018 | -69.17% |
| Dec 31, 2015 | 2,354,200.00% |
| Sep 30, 2015 | -99.99% |
| Jun 30, 2015 | -79.54% |
| Mar 31, 2015 | -26.38% |